Xiaoqing Li
机构:Hebei Medical University, Center for Biologics Evaluation and Research, United States Food and Drug Administration, Guangxi Medical University, Shanxi Medical University, South China Normal University, Chinese Academy of Medical Sciences & Peking Union Medical College, Wenzhou Medical University, Peking Union Medical College Hospital, Ministry of Education, Xi'an Medical University, Xingtai People's Hospital, The Affiliated Yongchuan Hospital of Chongqing Medical University, Women's Hospital, School of Medicine, Zhejiang University, Xi’an Children’s Hospital, Wenzhou City People's Hospital, Qilu Hospital of Shandong University, Shenzhen Second People's Hospital, Baoding People's Hospital, Southern Medical University, Chongqing Medical University · ORCID:0000-0002-9815-6040
发表论文 409 篇 · 总被引 8304 次 · h-index 49
代表论文
- Redox-responsive chitosan hydrogel releases mitochondria-targeted fullerenol to reprogram M1/M2 macrophage balance for diabetic wound healing (2025 · Journal of Controlled Release · 被引 6)
- Photocurrent polarity reversal induced by CuBi2O4 for sensitive photoelectrochemical detection of circulating tumor cells (2025 · Microchimica Acta · 被引 5)
- SQLE drives bladder cancer progression by boosting mitochondrial oxidative phosphorylation (2025 · Oncogene · 被引 3)
- A carboxymethyl chitosan/oxidized alginate hydrogel with controlled fullerenol release accelerates diabetic wound healing through cellular senescence reprogramming (2025 · Chemical Engineering Journal · 被引 3)
- From food-medicine homology to clinical potential: Plant-derived vesicle-like nanoparticles for inflammation management (2026 · Pharmacological Research · 被引 2)
- Efficacy and Safety of Firsekibart in Treatment of Active Systemic Juvenile Idiopathic Arthritis: A Randomized Phase 2 Study (2026 · Rheumatology and Therapy · 被引 1)